-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.35M, a 6.87% decline year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$12.3M, a 3.87% decline year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$12.3M, a 3.87% decline from 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$11.9M, a 18.6% decline from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$10M, a 0.52% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)